Global Pertussis Vaccine Consumption Market by Key Players 2026 | Sanofi Pasteur, Astellas Pharma, Minhai Biotechnology

According to OMR's analysis, the Pertussis Vaccine revenue had reached about 5147.12 million USD in 2016 from 4026.75 million USD in 2012 in global, with the CAGR of 6.33%.

Pertussis vaccine is a vaccine that protects against whooping cough.

There are two main types: Whole-cell vaccines and Acellular vaccines. The whole-cell vaccine is about 78% effective while the Acellular vaccine is 71–85% effective. The sales proportion of Acellular vaccines in 2016 was about 92.6%.

The Pertussis Vaccine can be used for Children and Adults. The most proportion of Pertussis Vaccine was adults, and the sales proportion was about 93.6% in 2016.

Key market participants covered in the report include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Astellas Pharma, Minhai Biotechnology, Wuhan Institute of Biological Products and Changchun Changsheng Life Sciences.

Avail a UPTO 40% Discount on Purchase at: https://www.ozonemarketreports.com/discount-request/global-pertussis-vaccine-consumption-sales-market-report-2020/227534

Asia-Pacific was the largest sales place, with revenue market share about 38.7% in 2016. Following Asia-Pacific, Europe was the second largest sales place with the revenue market share of nearly 31.3%. North America, Latin America and Middle East and Africa are also important sales regions for Pertussis Vaccine.

Geographically, this report split global into several key Regions, with sales (K Units),
revenue (M USD), market share and growth rate of Pertussis Vaccine Consumption for these regions, from 2014 to 2026 (forecast), covering
• China
• USA
• Europe
• Japan
• Korea
• India
• Southeast Asia
• South America

Global Pertussis Vaccine Consumption market competition by top manufacturers/players,
with Pertussis Vaccine Consumption sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
• Sanofi Pasteur
• GSK
• Mitsubishi Tanabe Pharma
• Astellas Pharma
• Minhai Biotechnology
• Wuhan Institute of Biological Products
• Changchun Changsheng Life Sciences
• Other

Browse Full Report at: https://www.ozonemarketreports.com/pharmaceuticals-and-healthcare/global-pertussis-vaccine-consumption-sales-market-report-2020/227534

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Whole-cell vaccines
• Acellular vaccines

On the basis on the end users/applications,
this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pertussis Vaccine Consumption for each application, including
• Children Application
• Adults Application

If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:
Name: Steven Samuel
Email - info@ozonemarketreports.com
Phone - +91 9370882135
Website: https://www.ozonemarketreports.com/

About Us

Ozone Market Reports is committed to delivering intensive research-based analysis reports, enabling clients to easily make fact-based decisions. We also have with us the facility of our innovatively designed and developed data processing and analysis division.

Ozone Market Reports is a research-based consulting firm specializing in getting research inputs and using them appropriately in the marketing planning process. In saying this, we are trying to convey that we always attempt to interpret the research data from the viewpoint of recommending action priorities - both short-term and long-term. To this end, we have put together a team that understands not only research techniques, but also branding concepts in depth. We believe our people are our clients' biggest assets hence we do our best to recruit multi-skilled individuals, and then give them an environment where they can think and ideate freely.

This release was published on openPR.